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Abstract
• Background: The present study was performed to investigate the influence of extracellular magnesium on changes in contractile tone induced by endothelin-1, and on relaxations to bradykinin in isolated porcine ciliary arteries.
• Methods: Vessels were studied in a myograph system for measurement of isometric forces.Concentrationresponse curves (10-10-10-7 M) to endothelin-1 were constructed in the presence of different concentrations (0, 1.2, 2, 10 mM) of magnesium (MgSO4). Endothelin-l-precontracted vessels ('10-8 M) were exposed to magnesium (10-5-10-2 M) in the presence or absence of either the inhibitor of nitric oxide formation L-NAME (-10-4 M), or different concentrations of calcium (2.5, 5, 10 mM). In endothelin-l-precontracted vessels (10-8 M) , relaxations to bradykinin (10-10-10 M) were conducted in the presence of different concentrations of magnesium (0, 1.2, 10 mM).
• Results: Contractions to endothelin-1 were reduced only in the presence of 10 mM magnesium. (1.2 mM vs 10 mM, P = 0.001). In endothelin-l-precontracted vessels, magnesium evoked complete concentration-dependent relaxations (pD2 = 3.1 ± 0.1), which were shifted to the right by increasing extracellular concentrations of calcium (2.5 vs 5 mM, P < 0.05). L-NAME had no influence on magnesium-induced relaxations. Relaxations to bradykinin remained unaffected by changes in extracellular magnesium concentrations.
• Conclusions: In a mechanism which appears to be compatible with a calcium-antagonist effect, magnesium strongly modulates changes in contractile tone evoked by endothelin-1, but has no effect on bradykinin-induced relaxations.
Introduction
Various endothelial-derived substances modulate vascular tone. Among them are the potent vasoconstrictor, endothelin-1, and the vasorelaxing factor, nitric oxide (NO) [11, 12, 20, 23] .
Endothelin-1, after binding to specific receptors on vascular smooth muscle cells, activates phospholipase C and leads -via formation of inositol triphosphate and diacylglycerol -to an increase in intracellular calcium and eventually to a contraction [21, 29] . In some vascular beds, the endothelin-l-induced intracellular calcium increase has been shown to be, in part, due to an influx of extracellular calcium through voltage-operated channels [10] . As a result, in certain vascular beds, calcium antagonists are effective in inhibiting endothelin-1-induced contractions [15] . For example, in the ophthalmic circulation, modulation of endothelin-l-induced contractions by calcium antagonists could be shown [24, 27] .
NO is formed from L-arginine by a specific NO synthase in endothelial cells under basal conditions or after activation by some agonists, such as bradykinin [20] . In vascular smooth muscle cells, NO stimulates a guanylate cyclase, which in turn increases intracellular cGMP con-centration and leads, by lowering the intracellular calcium concentration, to a relaxation [28] .
Extracellular magnesium concentration modulates vascular contractile tone. In precontracted vessels, magnesium causes vasorelaxations, and contractions to various agonists were attenuated in the presence of high concentrations of magnesium [1, 3, 6, 18, 31, 32] . These effects have usually been attributed to a calcium-antagonist-like mechanism [13, 14, 18] and it has been suggested that magnesium is able to regulate calcium flux across the vascular smooth muscle cell membranes. It has also been reported that magnesium could interfere with the calcium release from intracellular storage sites, as well as with the basal formation and/or the release of NO [9, 17] .
This study investigates, in isolated porcine ciliary arteries, the influence of magnesium on contractions to endothelin-1 and on NO-induced endothelium-dependent relaxations evoked by bradykinin [34] .
Drugs
Bradykinin, L-NAME, indomethacin, and U46619 were obtained from Sigma Chemical (St. Louis, Mo.), and endothelin-1 from Novabiochem (Laufigen, Switzerland). All drugs were dissolved in distilled water except U46619 and indomethacin, which were dissolved in 10-5 M Na2CO3, and endothelin-1, which was dissolved in Krebs solution containing 0.05% bovine serum albumin. Concentrations were expressed as final molar concentrations in the organ chamber.
Statistical analysis
Contractions were expressed as percentage of contraction to 100 mM KCl and relaxations as percentage of the precontraction to endothelin-1 (10-s M). The concentration causing 50% of the maximal response (EC50 value) was expressed as a negative log M concentration (pD2 value). Results are given as mean ± standard error of the mean (mean ± SEM), and n equals the number of eyes (one eye per animal). For statistical comparison analysis of variance (ANOVA; Scheffe's F test) was used. A two-tailed P value smaller than 0.05 was considered to be statistically significant.
Materials and methods

Blood-vessel preparation
Porcine eyes were obtained at a slaughterhouse just after death of animals. In cold modified Krebs-Ringer solution (NaCI 118 mM, KCl 4.7 mM, CaC12 2.5 mM, KH2PO4 1.2 mM, MgSO4 1.2 mM, NaHCO3 25 mM, glucose 11.1 mM), ciliary arteries were isolated and cut into 2-mm-long rings [25] . In an organ chamber, two 40-µm stainless wires were passed through the vessel's lumen and attached to a force transducer for isometric force measurement and to a micromanipulator (Myo-Interface, JP Trading, Aarhus, Denmark). Vessels were left for 30 min for equilibration in the modified Krebs-Ringer solution (95% 02, 5% CO2, 37 °C, and indomethacin 10-5 M to block prostaglandin synthesis). Vessels were then stretched in a stepwise fashion to reach their optimal passive tension (ca. 950 mg) [11, 24] .Then vessels were exposed several times to KC1 100 mM until they showed reproducible contractions (i.e. less than 10% variation between two successive KCl-induced contractions). The endothelial function was considered to be intact if bradykinin (10-8-10-6 M) evoked more than 80% relaxation of a vessel precontracted with the thromboxane A2 analog U46619 (10 -7 M).
Experimental protocol
In the presence of different concentrations of magnesium (0, 1.2, 2, and 10 mM), concentration-response curves to ET-1 (10-10-10-7 M) were constructed. Isotonicity was maintained by adjusting the NaCl concentration. In another set of experiments endothelin-l-precontracted vessels ('10-s M) were exposed to increasing concentrations of MgC12 and/or MgSO4 (10-5-10-2 M): (a) in the presence or absence of the inhibitor of nitric oxide formation 1VG-nitro-L-arginine methyl ester (L-NAME; 10 -4 M), and (b) in the presence of different concentrations of Cat (2.5, 5, and 10 mM). In all these experiments, the precontraction to endothelin-1 was achieved in a magnesiumfree medium. To rule out an osmolarity effect, a control was conducted with NaCl (same osmolarity as MgSO4). Finally, after precontracting vessels with endothelin-1 ( , 10-8 M), a relaxation-response curve to bradykinin (10-10-10 M) was constructed in the presence of different concentrations of magnesium (0, 1.2, and 10 mM). It has to be mentioned that concentrations of ET-1 were adapted (10-8 M to 3x10 8 M) in order to reach equivalent levels of precontraction.
Results
Magnesium modulates endothelin-l-induced contractions
In porcine ciliary arteries, endothelin-1-induced, under control conditions (Mg2, 1.2 mM), potent concentrationdependent contractions, with a maximal effect of 111 ± 4% of KCI 100 mM contraction and a pD2 value of 7.9 ± 0.1 (Fig. 1 ). Responses were not significantly affected by decreasing magnesium concentrations to 0 mM or increasing to 2 mM. Only at a concentration of 10 mM could a significant reduction of the maximal contractile effect of endothelin-1 be observed (E mzx = 80 ± 6%, P = 0.001 vs control).
Magnesium relaxes endothelin-l-precontracted vessels
In arteries precontracted with endothelin-1 (10-8 M) in magnesium-free medium, both MgC12 and MgSO 4 (10-5 (-log M)
Bradykinin (-log M) Fig. 4 Effect of different extracellular MgSO4 concentrations on bradykinin-induced relaxations. In comparison to control experiments (1.2 mM), the relaxation-response curve to bradykinin appeared to be unaffected by changes of the extracellular magnesium concentrations -10-2 M) evoked complete concentration-dependent relaxations (MgC12: relaxmax = 95 ± 1%, pD2 =3.1 ± 0.1). The two magnesium salts showed similar concentrationrelaxation curves, whereas NaCl had no relaxing effect, excluding an unspecific effect of magnesium related to changes in osmolarity. Furthermore, the relaxing effect of MgSO4 was unaffected by the inhibitor of NO formation, L-NAME (10 M), demonstrating that in porcine ciliary arteries NO is not involved in the relaxation evoked by magnesium (Fig. 2) .
Extracellular calcium concentration modulates relaxations to magnesium
In vessels precontracted with endothelin-1 (_10-8 M) in magnesium-free medium, changes of the calcium concentration (2.5, 5, and 10 mM) in the medium affected the relaxation to MgCl2. Increasing extracellular calcium concentrations resulted in a rightward shift of the concentration-response curve (2.5 vs 5 mM: pD2 = 3.1 ± 0.1 vs pD2 = 2.5 ± 0.1, P<0.01; 5 vs 10 mM: pD2 = 2.5 ± 0.1 vs pD2 = 2.0 ± 0.0, P < 0.05) without affecting the maximal relaxing effect of magnesium (Fig. 3) .
Magnesium-and bradykinin-induced relaxations
In porcine ciliary arteries precontracted with endothelin-1 (-10-8 M), bradykinin (10-t 1 -10-6 M) evoked concentration-dependent relaxations. In comparison to control ex-periments the relaxation-response curve to bradykinin was not affected by changes in extracellular magnesium concentrations, demonstrating that in porcine ciliary arteries bradykinin-induced relaxations remain unaffected by changes of the extracellular magnesium concentration (Fig. 4) .
Discussion
The present study demonstrates that in porcine ciliary arteries, extracellular magnesium concentrations modulate changes in contractile tone induced by endothelin-1.
The potent contracting effect of endothelin-1 was blunted by elevated extracellular concentrations of magnesium, while in endothelin-l-precontracted vessels magnesium evoked potent and complete relaxations in a concentration-dependent manner. The magnesium-induced relaxations were shifted to the right by increasing the extracellular concentration of calcium. Finally, relaxations to bradykinin remained unaffected by changes in extracellular concentrations of magnesium. Magnesium has been shown to have calcium-antagonist-like properties [13, 14] and to inhibit calcium influx through voltage-operated calcium channels [ 18, 31] . In certain vascular beds calcium antagonists partially attenuate the contraction to endothelin-1 [15] , while they are more potent in reversing an endothelin-1-induced precontraction [33] . Therefore it has been suggested that in these vascular beds the development of endothelin-1-induced contractions is essentially dependent of the release of calcium from intracellular storage sites, while the maintenance of the contraction could involve voltage-operated calcium channels [33] . In a similar way, the present study shows that magnesium is less efficient in preventing the development of a contraction to endothelin-1 (when added before the contraction) than in reversing a contraction to endothelin-1 (when added once the contraction is fully developed). Indeed, in the presence of 10 mM of magnesium, the contraction to 10-8 M endothelin-1 was only partially inhibited (Fig. 1) , while once the contraction to 10-8 M endothelin-1 was fully developed, addition of 10 mM of magnesium evoked a complete relaxation of the vessels (Fig. 2) . A similar phenomenon has already been reported in goat cerebral arteries [32] , where magnesium reversed an endothelin-1-induced contraction, even though it had no significant effect when added before the contraction to endothelin-1.
The range of normal magnesium concentration in the plasma of healthy subjects ranges between 0.7 and 1.1 mmol/l. At concentrations as high as 1.5 mM first hemodynamic symptoms such as systemic hypotension and tachycardia can be observed. With higher concentrations (>7.5 mM) cardiac arrest can be induced [5] . The results of this in vitro pharmacological study clearly show that already at physiological magnesium concentrations (1.0 mM), about 50% relaxation can be observed in vessels precontracted with endothelin-1 in magnesium-free medium, while to blunt the development of a contraction evoked by endothelin-1 nonphysiological concentrations of magnesium are needed.
Endothelin-l-precontracted vessels were fully and concentration-dependently relaxed by MgSO4 and MgC12, whereas in comparison NaCl had no relaxing effect, ruling out an unspecific osmolarity effect of MgSO4 and thereby demonstrating that the observed relaxing effect was indeed due to magnesium (Fig. 2) . With increasing concentrations of calcium, the relaxation-response curve to magnesium was shifted to the right, demonstrating that the sensitivity to magnesium is closely related to the extracellular calcium concentration (Fig. 3) . This corroborates studies in which it has been suggested that magnesium is able to regulate calcium flux across the vascular smooth muscle cell membranes [3, 18, 30, 31] . Furthermore, this observation underlines the importance of the calcium/magnesium concentration ratio in the maintenance of contractions evoked by endothelin-1. Although the exact mechanism of magnesium-induced relaxations in porcine ciliary arteries remains to be further investigated, magnesium appears to have some calcium-antagonistic properties.
The mechanism of the effect of magnesium on vascular tone is still debated, and in some vascular beds NO has been shown to be involved in the relaxing effect of magnesium [19] . In porcine ciliary arteries L-NAME, an inhibitor of NO formation, did not affect the magnesium-induced relaxation, demonstrating that in these vessels the relaxing effect of magnesium does not involve NO. This is in agreement with some reports showing an endothelium independency of the relaxations to magnesium [2] .
In porcine ciliary arteries relaxations to bradykinin were unaffected by magnesium (Fig. 4) , demonstrating that the NO production and action evoked by bradykinin is unaffected by changes in the extracellular magnesium concentration. This corroborates the lack of effect of calcium antagonists on bradykinin-induced relaxations in porcine ciliary arteries [24] .
In conclusion, magnesium, which appears to share some common features with calcium antagonists, is a potent modulator of endothelin-1-induced contractions in porcine ciliary arteries. As calcium antagonists have been proposed for the treatment of some ocular vascular diseases [8, 16, 26] , magnesium, due to its calcium antagonist properties, could be considered as a potential alternative [7] . Such an approach has already been proposed for the treatment of several vascular diseases, such as migraine [4, 22] .
